Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

G. Daniele, L. Arenare, G. Scambia, C. Pisano, R. Sorio, E. Breda, S. De Placido, A. Savarese, G. Ferrandina, F. Raspagliesi, P. B. Panici, A. Ferro, A. Rimanti, G. Cormio, D. Lorusso, S. C. Cecere, S. Scalone, V. A. Marsico, C. Cardalesi, F. CognettiV. Salutari, L. Attademo, L. Guizzaro, C. Schettino, M. C. Piccirillo, F. Perrone, C. Gallo, S. Pignata

Research output: Contribution to journalArticlepeer-review


BACKGROUND: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Original languageItalian
Pages (from-to)83-88
Number of pages6
JournalGynecologic Oncology
Issue number1
Publication statusPublished - 2019

Cite this